Ftse Mib
36.471,75
0,12%
DAX
21.732,05
0,01%
S&P 500
6.040,53
-0,50%
NASDAQ
19.627,44
-0,28%
Bitcoin
102.410,59
0,00%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Clearside Biomedical Inc (CLSD) Clearside Biomedical Inc (CLSD) Notizie

Clearside Biomedical Inc

CLSD
0,9499
0,0049 (0,52%)
01 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/1/202513:05GLOBEClearside Biomedical Announces Multiple Medical Meeting..
22/1/202513:05GLOBEClearside Biomedical Announces its Asia-Pacific Partner,..
10/1/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202413:05GLOBEClearside Biomedical Announces Publication of Critical..
25/11/202413:05GLOBEClearside Biomedical Extends Global Footprint with Numerous..
12/11/202422:10EDGAR2Form 8-K - Current report
12/11/202422:05GLOBEClearside Biomedical Announces Third Quarter 2024 Financial..
07/11/202415:05GLOBEClearside Biomedical Partner Arctic Vision Executes..
06/11/202413:05GLOBEClearside Biomedical to Participate in Fireside Chat at the..
04/11/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202413:05GLOBEClearside Biomedical Appoints Tony Gibney as New Chair of..
31/10/202412:05GLOBEClearside Biomedical to Report Third Quarter 2024 Financial..
22/10/202413:05GLOBEClearside Biomedical’s Positive ODYSSEY Wet AMD Data and..
09/10/202413:55EDGAR2Form 8-K - Current report
09/10/202412:30GLOBEClearside Biomedical Announces Positive Topline Results from..
27/8/202413:05GLOBEClearside Biomedical Announces Completion of Final..
12/8/202422:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202422:15EDGAR2Form 8-K - Current report
12/8/202422:05GLOBEClearside Biomedical Announces Second Quarter 2024 Financial..
08/8/202413:05GLOBEClearside Biomedical to Participate in the H.C. Wainwright..
01/8/202413:05GLOBEClearside Biomedical to Report Second Quarter 2024 Financial..
29/7/202422:05GLOBEClearside Biomedical’s Partner Arctic Vision Reports..
24/7/202413:55EDGAR2Form 8-K - Current report
22/7/202418:00GLOBEClearside Biomedical Opens Registration for Suprachoroidal..
11/7/202413:05GLOBEClearside Biomedical Appoints Dr. Glenn Yiu to its..
27/6/202413:05GLOBEClearside Biomedical to Host Virtual Key Opinion Leader..
12/6/202413:05GLOBEClearside Biomedical’s Leadership in Suprachoroidal Delivery..
21/5/202413:05GLOBEClearside Biomedical Announces Publication of Consensus..
10/5/202422:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/5/202422:10EDGAR2Form 8-K - Current report
09/5/202422:05GLOBEClearside Biomedical Announces First Quarter 2024 Financial..
08/5/202422:15GLOBEClearside Biomedical to Participate in Fireside Chat at the..
30/4/202413:05GLOBEClearside Biomedical to Report First Quarter 2024 Financial..
16/4/202413:05GLOBEClearside Biomedical Appoints Seasoned Biotechnology..
02/4/202413:05GLOBEClearside Biomedical to Participate in Fireside Chat at the..
18/3/202412:05GLOBEClearside Biomedical Appoints Victor Chong, M.D., MBA as..
12/3/202421:05GLOBEClearside Biomedical Announces Fourth Quarter and Full Year..
29/2/202413:05GLOBEClearside Biomedical to Report Fourth Quarter and Full Year..
08/2/202423:05EDGAR2Form 8-K - Current report
08/2/202422:52EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/2/202414:00GLOBEClearside Biomedical Announces Pricing of $15 Million..
Apertura: 0,9401 Min: 0,92 Max: 0,95
Chiusura: 0,945

La tua Cronologia

NASDAQ
CLSD
Clearside Biomedical
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci